SAN DIEGO, March 23, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and full year ended December 31, 2025. "2025 demonstrated ...
Bionano is guiding for full-year 2026 revenue of $30 million to $33 million, representing 5% to 16% growth over 2025. Q1 2026 revenue guidance is $6.5 million to $6.7 million, described as "flat to 3% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results